par Van Laethem, Jean-Luc ;Hammel, Pascal;Mornex, Françoise;Azria, David;Van Tienhoven, Geertjan;Vergauwe, Philippe;Peeters, Marc;Polus, Marc;Praet, Michel ;Mauer, Murielle;Collette, Laurence;Budach, Volker;Lutz, Manfred B.;Van Cutsem, Eric;Haustermans, Karin
Référence Journal of clinical oncology, 28, 29, page (4450-4456)
Publication Publié, 2010-10
Référence Journal of clinical oncology, 28, 29, page (4450-4456)
Publication Publié, 2010-10
Article révisé par les pairs
Titre: |
|
Auteur: | Van Laethem, Jean-Luc; Hammel, Pascal; Mornex, Françoise; Azria, David; Van Tienhoven, Geertjan; Vergauwe, Philippe; Peeters, Marc; Polus, Marc; Praet, Michel; Mauer, Murielle; Collette, Laurence; Budach, Volker; Lutz, Manfred B.; Van Cutsem, Eric; Haustermans, Karin |
Informations sur la publication: | Journal of clinical oncology, 28, 29, page (4450-4456) |
Statut de publication: | Publié, 2010-10 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Aged | |
Antimetabolites, Antineoplastic -- adverse effects -- therapeutic use | |
Chemotherapy, Adjuvant | |
Combined Modality Therapy | |
Deoxycytidine -- adverse effects -- analogs & derivatives -- therapeutic use | |
Diarrhea -- chemically induced | |
Drug Administration Schedule | |
Fatigue -- chemically induced | |
Feasibility Studies | |
Female | |
Humans | |
Kaplan-Meier Estimate | |
Male | |
Middle Aged | |
Nausea -- chemically induced | |
Pancreatic Neoplasms -- drug therapy -- radiotherapy -- surgery | |
Radiotherapy, Adjuvant | |
Treatment Outcome | |
Note générale: | Clinical Trial, Phase II |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, N.I.H., Extramural | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2010.30.3446 | |
info:pii/JCO.2010.30.3446 | |
info:pmid/20837948 | |
PMC2988636 |